Quidelortho CORP 8-K filings

QuidelOrtho has updated its 2024 financial guidance, widening the range for adjusted diluted EPS while maintaining the midpoint.

QuidelOrtho's fourth quarter and full-year 2023 results show a significant decline in respiratory revenue offset by growth in non-respiratory business and strategic investments.